A vaccine and diagnostic target for Clostridium bolteae, an autism-associated bacterium
Authors:
- Martin SagermannMSMartin Sagermann
- Moez VallianiMVMoez Valliani
- Michael TohMTMichael Toh
- Herbert ChowHCHerbert Chow
- Emma Allen-VercoeEAEmma Allen-Vercoe
- Mario A. MonteiroMMMario A. Monteiro
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Current State of Clostridium difficile Treatment OptionsClinical Infectious Diseases, 2012
- Microbiology of regressive autismAnaerobe, 2012
- Campylobacter Polysaccharide Capsules: Virulence and VaccinesFrontiers in Cellular and Infection Microbiology, 2012
- Pyrosequencing study of fecal microflora of autistic and control childrenAnaerobe, 2010
- Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disordersBehavioural Brain Research, 2007
- Differences between the gut microflora of children with autistic spectrum disorders and that of healthy childrenJournal of Medical Microbiology, 2005
- Clostridium bolteae sp. nov., Isolated from Human SourcesSystematic and Applied Microbiology, 2003
- Gastrointestinal Microflora Studies in Late‐Onset AutismClinical Infectious Diseases, 2002
- Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset AutismJournal of Child Neurology, 2000
- Short‐chain fatty acids present in the ileum inhibit fasting gastrointestinal motility in conscious pigsNeurogastroenterology & Motility, 1999